StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$6.24−0.07 (-1.11%)

Close on Nov 12, 2026Market cap $42.32MP/E –Yield –

Instil Bio profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Instil Bio's profit margin for the twelve months ending Jun 30, 2021 was -159396.2%. For fiscal 2020 it was -27346.4%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-27346.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 2020-13965.4%–
Q2 FY2020Jun 30, 2020-21909.5%–
Q1 FY2020Mar 31, 2020-9293.2%–

More Instil Bio figures

See a number that looks wrong?